Učitavanje...
Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery
BACKGROUND: Warfarin is an anticoagulant and is widely used for the prevention of thromboembolic events. Genetic variants of the enzymes that metabolize warfarin, i.e. cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1), contribute to differences in patients’ responses to various w...
Spremljeno u:
| Izdano u: | Res Cardiovasc Med |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Kowsar
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4592525/ https://ncbi.nlm.nih.gov/pubmed/26448196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/cardiovascmed.27963v2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|